GARDP, CHAI and Shionogi collaborate to accelerate access to antibiotic for bacterial infections

By | July 13, 2021
The Global Antibiotic Research and Development Partnership, the Clinton Health Access Initiative and Shionogi & Co., Ltd today announced a Memorandum of Understanding to accelerate access, including in low- and middle-income countries, to the antibiotic cefiderocol for bacterial infections in patients with limited treatment options.